Achieve Life News

Express News | Achieve Life Sciences Files Prospectus Related To Offer & Sale From Time To Time Of Up To 13.1M Shares Of Common Stock, By Selling Stockholders

Benzinga16:39 ET

Express News | Achieve Life Sciences- Files Prospectus Related to Offer & Sale From Time to Time of up to 13.1 Mln Shares of Common Stock,by Selling Stockholders

Reuters16:36 ET

Jones Starts Achieve Life Sciences at Buy, Cites Market Opportunity

Seeking AlphaApr 17 17:41 ET

Express News | JonesTrading Initiates Coverage On Achieve Life Sciences With Buy Rating, Announces Price Target of $20

Moomoo 24/7Apr 17 10:14 ET

Express News | Achieve Life Sciences Inc : Jonestrading Initiates Coverage With Buy Rating; Target Price $20

Moomoo 24/7Apr 17 00:55 ET

Achieve Life Sciences: A Strong Buy for Tobacco Cessation Market Penetration

TipRanksApr 16 16:25 ET

Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference

Achieve Life Sciences, Inc. (Nasdaq: ACHV) today announced that John Bencich, CEO of Achieve, will present at the Life Science Innovation Northwest (LSINW) 2024 Conference being held at the Seattle Convention Center April 17-18, 2024.

GlobeNewswireApr 11 08:00 ET

Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q4 2023 Earnings Call Transcript

Yahoo FinanceApr 1 15:30 ET

Express News | Oppenheimer Reiterates Outperform on Achieve Life Sciences, Maintains $18 Price Target

Moomoo 24/7Apr 1 09:14 ET

Achieve Life Sciences Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 286.27% Oppenheimer $18 → $18 Reiterates Outperform → Outperform 03/05/2024 136.05% Lake Street

BenzingaApr 1 09:14 ET

Institutional Investors Own a Significant Stake of 36% in Achieve Life Sciences, Inc. (NASDAQ:ACHV)

Key Insights Institutions' substantial holdings in Achieve Life Sciences implies that they have significant influence over the company's share price The top 4 shareholders own 51% of the company

Simply Wall StApr 1 09:03 ET

Analysts Offer Insights on Healthcare Companies: Achieve Life Sciences (ACHV) and Phathom Pharmaceuticals (PHAT)

TipRanksApr 1 06:50 ET

Q4 2023 Achieve Life Sciences Inc Earnings Call

Yahoo FinanceMar 29 06:24 ET

Earnings Call Summary | Achieve Life(ACHV.US) Q4 2023 Earnings Conference

The following is a summary of the Achieve Life Sciences, Inc. (ACHV) Q4 2023 Earnings Call Transcript:Financial Performance:Achieve Life Sciences reported a decrease in cash, cash equivalents, and res

moomoo AIMar 28 21:33 ET · Conference Call

Achieve Life Sciences Inc Reports Year-End Loss, Progresses Towards FDA Approval

Yahoo FinanceMar 28 17:32 ET

Recap: Achieve Life Sciences Q4 Earnings

Achieve Life Sciences (NASDAQ:ACHV) reported its Q4 earnings results on Thursday, March 28, 2024 at 04:01 PM.Here's what investors need to know about the announcement.EarningsAchieve Life Sciences bea

BenzingaMar 28 16:15 ET

Achieve Life Sciences GAAP EPS of -$0.26 Beats by $0.05

Seeking AlphaMar 28 16:04 ET

Achieve Life Sciences 4Q Loss/Shr 26c >ACHV

Achieve Life Sciences 4Q Loss/Shr 26c >ACHV

Dow JonesMar 28 16:01 ET

Press Release: Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update

Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2023 and Provides Corporate Update Company to host conference call at 4:30 PM EDT today, Thursday, March 28, 2024 SEAT

Dow JonesMar 28 16:01 ET

Calendar of U.S. Earnings Expected in the Week Ahead

Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc. Company Symbo

Dow JonesMar 28 06:00 ET